Indications

Mesh Heading Maximum Phase Mesh ID Reference
Melanoma 3 D008545 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
HIV Infections 2 D015658 ClinicalTrials
Glioblastoma 2 D005909 ClinicalTrials
Lymphoma 2 D008223 ClinicalTrials
Neuroblastoma 2 D009447 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
HIV Infections 2 D015658 ClinicalTrials
Mesothelioma 2 D008654 ClinicalTrials
Varicose Ulcer 2 D014647 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 2 D002289 ClinicalTrials
Colonic Neoplasms 2 D003110 ClinicalTrials
Glioma 2 D005910 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Nasopharyngeal Neoplasms 2 D009303 ClinicalTrials
Peripheral Arterial Disease 2 D058729 ClinicalTrials
Appendicitis 2 D001064 ClinicalTrials
Burkitt Lymphoma 2 D002051 ClinicalTrials
Lymphoma, Large B-Cell, Diffuse 2 D016403 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Pulmonary Alveolar Proteinosis 2 D011649 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Kidney Neoplasms 1 D007680 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2107881
FDA SRS KR89Q40F01